Letter to the Editor

Cancer Chemotherapy and Pharmacology

, Volume 67, Issue 4, pp 967-969

Open Access This content is freely available online to anyone, anywhere at any time.

Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia

  • Grzegorz HelbigAffiliated withDepartament of Haematology and Bone Marrow Transplantation, Silesian Medical University Email author 
  • , Andrzej MoskwaAffiliated withDepartment of Haematology, Provincial Hospital
  • , Marek HusAffiliated withDepartment of Haematology, Medical University
  • , Jarosław PiszczAffiliated withDepartment of Haematology, Medical University
  • , Alina SwiderskaAffiliated withDepartment of Haematology, Provincial Hospital
  • , Alina UrbanowiczAffiliated withDepartment of Haematology, Provincial Hospital
  • , Małgorzata CałbeckaAffiliated withDepartment of Haematology, Provincial Hospital
  • , Ilona SeferyńskaAffiliated withInstitute of Haematology and Transfusion Medicine, Medical University
  • , Małgorzata RaźnyAffiliated withDepartment of Haematology and Internal Medicine, Rydygier Hospital
    • , Marek RodzajAffiliated withDepartment of Haematology and Internal Medicine, Rydygier Hospital
    • , Ewa ŻukAffiliated withDepartament of Haematology and Bone Marrow Transplantation, Silesian Medical UniversityDepartment of Haematology, Provincial Hospital
    • , Sławomira Kyrcz-KrzemieńAffiliated withDepartament of Haematology and Bone Marrow Transplantation, Silesian Medical University